EUVIMEDEUVIMED entdecken
Open Access

CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells

Xu Wang, Pu Wang, Qi Zhou, Xianzheng Wei, Yuhang Jin, Ying Liao, Xuan Zhao, Rui Hou, Sijin Li, Zhangchun Guan, Wen Ma, Dan Liu und 1 weitere

Theranostics · 2026

DOI: 10.7150/thno.125983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Xu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, T-Lymphocytes, Immunotherapy, Adoptive. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingT-LymphocytesImmunotherapy, AdoptiveHumansFemaleCytokinesMaleCD8-Positive T-LymphocytesMiddle AgedAgedGene Expression Profiling

Stichwörter der Autor:innen

CAR-T cell therapyCIDPMMT cell heterogeneityautoimmune diseasestranscriptomic reprogramming

Substanzen

Cytokines

Autor:innen und Institutionen

  • Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
  • Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, 99 Huaihai Road, Xuzhou, Jiangsu, 221002, China.
  • Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
  • Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250013, China.
  • College of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Zitieren

APA

Wang, X., Wang, P., Zhou, Q., Wei, X., Jin, Y., Liao, Y., Zhao, X., Hou, R., Li, S., Guan, Z., Ma, W., Liu, D., & Shi, M. (2026). CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells. Theranostics. https://doi.org/10.7150/thno.125983

Vancouver

Wang X, Wang P, Zhou Q, Wei X, Jin Y, Liao Y, et al. CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells. Theranostics. 2026. doi:10.7150/thno.125983

BibTeX
@article{Wang2026,
  author = {Wang, Xu and Wang, Pu and Zhou, Qi and Wei, Xianzheng and Jin, Yuhang and Liao, Ying and Zhao, Xuan and Hou, Rui and Li, Sijin and Guan, Zhangchun and Ma, Wen and Liu, Dan and Shi, Ming},
  title = {CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.125983}
}
Kostenlos starten →